Works matching IS 09024441 AND DT 2009 AND VI 82 AND IP 6
Results: 14
Reduction in labile plasma iron during treatment with deferasirox, a once-daily oral iron chelator, in heavily iron-overloaded patients with β-thalassaemia.
- Published in:
- European Journal of Haematology, 2009, v. 82, n. 6, p. 454, doi. 10.1111/j.1600-0609.2008.01204.x
- By:
- Publication type:
- Article
A reply to Efficaces’ letter to the editor.
- Published in:
- 2009
- By:
- Publication type:
- Letter
<sup>18</sup>F-Fluorodeoxyglucose positron emission tomography in primary cutaneous NK/T cell lymphoma, nasal type.
- Published in:
- 2009
- By:
- Publication type:
- Other
Efficacy and safety of deferasirox, an oral iron chelator, in heavily iron-overloaded patients with β-thalassaemia: the ESCALATOR study.
- Published in:
- European Journal of Haematology, 2009, v. 82, n. 6, p. 458, doi. 10.1111/j.1600-0609.2009.01228.x
- By:
- Publication type:
- Article
The role of Th17 cells in adult patients with chronic idiopathic thrombocytopenic purpura.
- Published in:
- 2009
- By:
- Publication type:
- Letter
Plasma-based detection of clonality in lymphoid malignancies.
- Published in:
- European Journal of Haematology, 2009, v. 82, n. 6, p. 450, doi. 10.1111/j.1600-0609.2009.01231.x
- By:
- Publication type:
- Article
Erythroid Kruppel-like factor (EKLF) is recruited to the γ- globin gene promoter as a co-activator and is required for γ- globin gene induction by short-chain fatty acid derivatives.
- Published in:
- European Journal of Haematology, 2009, v. 82, n. 6, p. 466, doi. 10.1111/j.1600-0609.2009.01234.x
- By:
- Publication type:
- Article
AIDS-related plasmablastic lymphoma with dramatic, early response to bortezomib.
- Published in:
- 2009
- By:
- Publication type:
- Letter
Oxidised low-density lipoprotein and arterial function in β-thalassemia major.
- Published in:
- European Journal of Haematology, 2009, v. 82, n. 6, p. 477, doi. 10.1111/j.1600-0609.2009.01236.x
- By:
- Publication type:
- Article
A review of pulmonary coagulopathy in acute lung injury, acute respiratory distress syndrome and pneumonia.
- Published in:
- European Journal of Haematology, 2009, v. 82, n. 6, p. 413, doi. 10.1111/j.1600-0609.2009.01238.x
- By:
- Publication type:
- Article
Synergistic interaction of the histone deacetylase inhibitor SAHA with the proteasome inhibitor bortezomib in cutaneous T cell lymphoma.
- Published in:
- European Journal of Haematology, 2009, v. 82, n. 6, p. 440, doi. 10.1111/j.1600-0609.2009.01239.x
- By:
- Publication type:
- Article
Asking patients with hematological malignancies: ‘how do you feel?’ Does it really provide independent prognostic information for survival?
- Published in:
- 2009
- By:
- Publication type:
- Letter
Lenalidomide in combination with dexamethasone at first relapse in comparison with its use as later salvage therapy in relapsed or refractory multiple myeloma.
- Published in:
- European Journal of Haematology, 2009, v. 82, n. 6, p. 426, doi. 10.1111/j.1600-0609.2009.01257.x
- By:
- Publication type:
- Article
Bortezomib, ascorbic acid and melphalan (BAM) therapy for patients with newly diagnosed multiple myeloma: an effective and well-tolerated frontline regimen.
- Published in:
- European Journal of Haematology, 2009, v. 82, n. 6, p. 433, doi. 10.1111/j.1600-0609.2009.01244.x
- By:
- Publication type:
- Article